• Adipose-Neural Signaling in Cardiac Arrhythmia

  2026-08-29

  Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY/Y1R pathway. The study links this signaling to NCX and CaMKII activity and supports the adipose-neural axis as a mechanistic framework for understanding cardiac arrhythmia.

• Adefovir Workflows for HBV and OAT1 Research

  2026-08-28

  Adefovir, also known as GS-0393, supports two complementary research workflows: mechanistic hepatitis B virus studies and quantitative OAT1 transporter phenotyping. This practical guide covers solution preparation, concentration selection, assay controls, structural-assay translation, and troubleshooting for reproducible results.

• Perospirone (SM-9018 freebase): Assay Guide

  2026-08-28

  This scenario-driven guide explains how SKU BA5009 can be incorporated into cell viability, proliferation, cytotoxicity, receptor, and vascular ion-channel workflows. It emphasizes solvent control, concentration interpretation, storage, and the distinction between receptor affinity and assay-specific biological effects.

• SAR131675: VEGFR-3 Inhibitor Workflow

  2026-08-27

  Build mechanistic lymphangiogenesis, endothelial migration, and tumor-growth assays around SAR131675, a selective ATP-competitive VEGFR-3 inhibitor. The workflow combines nanomolar pathway control with selectivity checks, solubility safeguards, and a cautious bridge to nicotine-associated kidney disease research.

• Fast HepaRG Differentiation for HBV and HDV Studies

  2026-08-27

  Lucifora and colleagues developed a shortened chemical differentiation strategy that produces HepaRG cells capable of efficient HDV infection after only one week, while revealing a distinct limitation in HBV cccDNA establishment. The work provides a faster antiviral model and a useful experimental framework for separating viral entry from the host-cell processes required to form the HBV nuclear minichromosome.

• Tropisetron Hydrochloride: From Receptor to Transporter

  2026-08-26

  Tropisetron Hydrochloride is more than a 5-HT3 receptor antagonist: it is a useful translational probe for connecting serotonin biology, α7-nicotinic receptor signaling, and renal transporter risk in mechanism-driven research.

• HSP90–METTL3–MYC Axis in Colorectal Cancer

  2026-08-26

  The reference study identifies METTL3 as an HSP90 client protein and links its chaperone-dependent stability to MYC mRNA m6A modification in colorectal cancer. Pharmacological disruption of the HSP90–METTL3 pathway promotes CHIP-mediated METTL3 degradation, reduces MYC RNA stability, and suppresses malignant cell phenotypes, while also illustrating the importance of protease-controlled sample handling for protein-level validation.

• Protease Inhibitor Cocktail for Ferroptosis Assays

  2026-08-25

  Learn how a Protease Inhibitor Cocktail EDTA-Free can improve protein-level readouts in AML ferroptosis research. This assay-focused guide connects ACSL4-driven lipid remodeling with practical lysate preservation, phosphorylation analysis, and endpoint selection.

• CUDC-907 Protocol and QC Guide

  2026-08-25

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled cell-based studies of PI3K/AKT signaling, epigenetic regulation, cell-cycle progression, and apoptosis. This guide covers dossier-based handling and workflow controls; it is not a clinical, diagnostic, or therapeutic protocol.

• Sumatriptan Succinate: Mechanism & Research Use

  2026-08-24

  Sumatriptan Succinate is a selective 5-HT1 receptor agonist with established relevance to migraine research and serotonergic signaling research. Evidence supports 5-HT1B/1D-mediated neurovascular effects, while pediatric emergency data support intranasal use as a feasible pathway treatment rather than a universally proven standard.

• Sisomicin: Mechanism, Evidence, and Research Use

  2026-08-24

  Sisomicin is a broad-spectrum aminoglycoside antibiotic that inhibits bacterial protein synthesis through interaction with the 30S ribosomal subunit. Its research use spans in vitro antibacterial testing, animal infection models, and avian inner-ear experiments, but susceptibility, renal function, ototoxicity, and nephrotoxicity require context-specific interpretation.

• KN-62 CaMKII Inhibition: Evidence & Use

  2026-08-23

  KN-62, also known as 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, is a research inhibitor of calcium/calmodulin-dependent protein kinase II. Product information reports a CaMKII Ki of 0.9 μM and applications spanning secretion, skeletal-muscle glucose transport, and K562 cell-cycle studies.

• Cannabidiol in Orofacial Inflammatory Pain: Study Analysis

  2026-08-22

  This 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce inflammatory pain while also improving affective and cognitive abnormalities in mouse models. Its central innovation is a multi-level analysis linking peripheral cannabinoid signaling, trigeminal and cortical neuronal activity, endocannabinoid changes, and serotonin dynamics in the central amygdala.

• Viral RIPK3 Degradation and Inflammation

  2026-08-21

  The Immunity study identified a conserved orthopoxvirus factor, vIRD, that recruits SCF machinery to ubiquitinate and degrade RIPK3, suppressing necroptosis while enhancing viral fitness. Its genetic and infection-model evidence shows that viral manipulation of host protein degradation can simultaneously shape inflammation, replication, and disease severity.

• Fluoxetine HCl: Reproducible Cell Assays

  2026-08-21

  Learn how Fluoxetine HCl (SKU A2436) can support reproducible cell-based studies of serotonergic signaling, receptor function, proliferation, and viability. This scenario-driven guide distinguishes pathway activity from cytotoxicity and provides practical handling, concentration-selection, interpretation, and vendor-evaluation guidance.

7892 records 1/527 page Next 12345 下5页 Last page